ES2096040T3 - Nuevo reactivo para la representacion grafica de los tumores y su terapia. - Google Patents

Nuevo reactivo para la representacion grafica de los tumores y su terapia.

Info

Publication number
ES2096040T3
ES2096040T3 ES92307198T ES92307198T ES2096040T3 ES 2096040 T3 ES2096040 T3 ES 2096040T3 ES 92307198 T ES92307198 T ES 92307198T ES 92307198 T ES92307198 T ES 92307198T ES 2096040 T3 ES2096040 T3 ES 2096040T3
Authority
ES
Spain
Prior art keywords
oligopeptides
therapy
tumors
graphic representation
ldv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92307198T
Other languages
English (en)
Inventor
Alan William John Stuttle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Antisoma Ltd
Original Assignee
Antisoma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Antisoma Ltd filed Critical Antisoma Ltd
Application granted granted Critical
Publication of ES2096040T3 publication Critical patent/ES2096040T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Optics & Photonics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE PRESENTAN NUEVOS OLIGOPEPTIDOS PARA LA FORMACION DE IMAGENES Y LA TERAPIA DE TUMORES IN VIVO. LOS NUEVOS OLIGOPEPTIDOS SON OLIGOPEPTIDOS QUE CONTIENEN DE 4 A 50 UNIDADES DE PEPTIDOS QUE CONTIENEN COMO TRIPLETE CARACTERISTICO LA SECUENCIA LEU UNA FUERTE AFINIDAD AL ENLACE IN VIVO EN LOS LUGARES DE ENLACE DE TUMORES Y OTROS TEJIDOS. CON FINES DE DIAGNOSTICO, LOS OLIGOPEPTIDOS SE ETIQUETAN CON UNA ETIQUETA RADIOACTIVA, EJ. 125L, MIENTRAS QUE CON FINES TERAPEUTICOS, LOS OLIGOPEPTIDOS SE ENLAZAN QUIMICAMENTE A O SE CONJUGAN CON UNA CITOTOXINA, COMO POR EJEMPLO LA CADENA A DE LA RICINA.
ES92307198T 1991-08-06 1992-08-06 Nuevo reactivo para la representacion grafica de los tumores y su terapia. Expired - Lifetime ES2096040T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919116925A GB9116925D0 (en) 1991-08-06 1991-08-06 Novel reagent for tumour imaging and therapy

Publications (1)

Publication Number Publication Date
ES2096040T3 true ES2096040T3 (es) 1997-03-01

Family

ID=10699563

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92307198T Expired - Lifetime ES2096040T3 (es) 1991-08-06 1992-08-06 Nuevo reactivo para la representacion grafica de los tumores y su terapia.

Country Status (10)

Country Link
US (1) US5628979A (es)
EP (1) EP0527056B1 (es)
JP (1) JPH07503702A (es)
AT (1) ATE143813T1 (es)
DE (1) DE69214383T2 (es)
DK (1) DK0527056T3 (es)
ES (1) ES2096040T3 (es)
GB (1) GB9116925D0 (es)
GR (1) GR3022264T3 (es)
WO (1) WO1993002708A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
US5629287A (en) * 1991-01-18 1997-05-13 University College London Depot formulations
US5443815A (en) * 1991-11-27 1995-08-22 Diatech, Inc. Technetium-99m labeled peptides for imaging
GB9116925D0 (en) * 1991-08-06 1991-09-18 Antisoma Ltd Novel reagent for tumour imaging and therapy
US7097839B1 (en) 1993-10-26 2006-08-29 Thomas Jefferson University ST receptor binding compounds and methods of using the same
IT1261386B (it) * 1993-12-21 1996-05-20 Sorin Biomedica Spa Peptidi modificati con gruppo fosfinico per la marcatura con 99m-tc e 186-188-re o agenti paramagnetici.
US6576239B1 (en) * 1996-09-10 2003-06-10 The Burnham Institute Angiogenic homing molecules and conjugates derived therefrom
US6418338B1 (en) 1998-02-06 2002-07-09 Phylatron Ltd. Method for detecting and surgically removing lymphoid tissue involved in tumor progression
US20070231833A1 (en) * 2005-05-23 2007-10-04 Arcidiacono Steven M Labeled antimicrobial peptides and method of using the same to detect microorganisms of interest
CN108976280B (zh) * 2017-05-30 2021-09-24 首都医科大学 脂肪胺修饰的ldv,其合成,活性和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4691006A (en) * 1983-03-04 1987-09-01 Ohio State University Antigenic modification of polypeptides
US4767842A (en) * 1973-05-07 1988-08-30 The Ohio State University Antigenic modification of polypeptides
US5135736A (en) * 1988-08-15 1992-08-04 Neorx Corporation Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
WO1990009799A1 (en) * 1989-02-23 1990-09-07 Colorado State University Research Foundation GnRH ANALOGS FOR DESTROYING GONADOTROPHS
GB8914020D0 (en) * 1989-06-19 1989-08-09 Antisoma Ltd Synthetic peptides for use in thrombus detection
DE69012950T2 (de) * 1989-10-13 1995-03-16 Takara Shuzo Co Antikrebsmittel.
US5382569A (en) * 1991-05-16 1995-01-17 Warner-Lambert Company Endotherlin antagonists
GB9116925D0 (en) * 1991-08-06 1991-09-18 Antisoma Ltd Novel reagent for tumour imaging and therapy

Also Published As

Publication number Publication date
EP0527056B1 (en) 1996-10-09
ATE143813T1 (de) 1996-10-15
EP0527056A1 (en) 1993-02-10
JPH07503702A (ja) 1995-04-20
GB9116925D0 (en) 1991-09-18
GR3022264T3 (en) 1997-04-30
DE69214383D1 (de) 1996-11-14
US5628979A (en) 1997-05-13
WO1993002708A1 (en) 1993-02-18
DK0527056T3 (da) 1996-12-30
DE69214383T2 (de) 1997-02-20

Similar Documents

Publication Publication Date Title
GR3026658T3 (en) Hydrazino-type radionuclide chelators having an n 3?s configuration
GB2241243A (en) Synthetic peptides for use in thrombus detection
EP0188256A3 (en) Metal radionuclide labeled proteins for diagnosis and therapy
SE8904087D0 (sv) Peptide derivates
DE69326335T2 (de) Technetium-99M-markierte peptide zur Bilderzeugung
AU7528894A (en) Hydrazino-type n2s2 chelators
PL374326A1 (en) Microoroganisms and cells for diagnosis and therapy of tumors
DE69329382T2 (de) Technetium-99m markierte peptide zur bilderzeugung von thrombus
ES2096040T3 (es) Nuevo reactivo para la representacion grafica de los tumores y su terapia.
DK0436005T3 (da) Mærkede polypeptidderivater
ZA954547B (en) Technetium-99m labeled peptides for imaging
HUP9801390A2 (hu) Diagnosztikai és terápiás célokra alkalmazható radioaktív módon jelzett peptidek
AU6198086A (en) Agents for use in tumour diagnosis, imaging, localization or treatment
DE69434384D1 (de) Metalkomplexbildner
HUT59833A (en) Process for producing pharmaceutical compositions containing calcitoninogene like peptides for treating erectional disfunctions
GR3002968T3 (en) Process for labelling substances with technetium or rhenium
KR930700163A (ko) 연조직 종양의 치료 및/또는 진단 방법
DK0478631T3 (da) Målsøgende midler
IL101675A0 (en) Method and pharmaceutical compositions for detecting and localizing tissues having neurokinine 1 receptors
DE69507408D1 (de) Peptide mit Affinität zu Tumoren und diese enthaltende radioaktive diagnostische und therapeutische Zusammensetzungen
EP0280135A3 (en) Protein c-inhibitor (pci) as a pharmaceutical and diagnostic agent, process for the preparation of such a pharmaceutical or diagnostic agent and a composition containing pci
EP0659764A3 (en) Peptides modified by a phosphine group for labeling with 99mTC and 186-188Re or paramagnetic agents.
AU8144894A (en) Biphenyl iodinated derivatives and their diagnostic use
AU7353400A (en) Macrocyclic chelants for metallopharmaceuticals

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 527056

Country of ref document: ES